National Cancer Action Center

WASHINGTON, D.C. – The following is a statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network: “The FDA’s job is to protect public health, not expand the profit margins of Big Tobacco. Authorizing new modified risk claims for 20 Zyn nicotine products – including flavored

WASHINGTON, D.C. – Yesterday, the U.S. Department of Health and Human Services (HHS) announced a coordinated effort across multiple agencies within the department to accelerate development of clinical research and remove barriers to clinical trial participation. As part of this initiative, the HHS Office of Inspector General (OIG)

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) submitted comments in a letter to the Department of Health and Human Services (HHS) and Centers for Medicare and Medicaid Services (CMS) applauding provisions of the 2026 Interoperability Standards and Prior Authorization for Drugs

Today, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).